Krystal Biotech, Inc. (KRYS)
Biological Products, (No Diagnostic Substances) · Healthcare · $9.5B
Intrinsic Value (Consensus)
$146.00
Current Price
$323.37
Margin of Safety
-54.9%
54.9% Above Intrinsic Value
Value: $146
Price: $323
Valuation Model Estimates
Current Price: $323.37
DCF (Discounted Cash Flow)
$300.95
Graham Number
$79.85
Earnings Power Value
$66.41
Relative Value (P/E)
$136.80
Dividend Discount Model
Not applicable
—
Consensus Value
$146.00
Model Assumptions
Discount Rate
10.3%
Growth Rate
20.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
B
75
Profitability
22/25
Strength
24/25
Valuation
7/25
Growth
22/25
Financial Health Signals
Low debt — conservative balance sheet
Strong earnings growth (20% YoY)
Key Financials
- EPS (TTM)
- $6.84
- EPS (Forward)
- $8.21
- Book Value
- $41.43
- P/E Ratio
- 20.0
- Forward P/E
- 16.7
- PEG Ratio
- —
- ROE
- 16.8%
- Debt/Equity
- 0%
- Revenue Growth
- 33.9%
- Earnings Growth
- 20.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance